Insights from 2024 ASCO® GU Annual Meeting


 

ASCO® GU 2024 Insights: "Subgroup Analyses of Efficacy Outcomes by Baseline Tumor Size in the CLEAR Trial - Lenvatinib & Pembro in 1L Treatment of aRCC"

87 views
March 5, 2024
Comments 0
Login to view comments. Click here to Login